Snake bites are not common in Australia, but cause severe effects and often occur in rural and regional parts of Australia. Antivenoms exist for the treatment of many of these … Continue reading Randomised Controlled Trial of Early Antivenom Administration in Australian Snakebite [ESAA]
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
A Phase 1, Single-Center, Open-label Study to Evaluate the Safety and Pharmacokinetics of Two Tablet Formulations of PRN1008. The purpose of this study is to investigate the relative bioavailability (the … Continue reading LE16061 Healthy Volunteer Trial
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Closed: follow-up complete
Have you been diagnosed with or suspected to have a nodular Basal Cell Carcinoma (BCC)? CLINICAL RESEARCH STUDY We are seeking volunteers with nodular BCC to participate in a … Continue reading A Phase I/IIa Study of the Efficacy and Safety of ASN-002 in Adult Patients with Low-Risk Nodular Basal Cell Carcinoma
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
This research project is testing the safety, tolerability and efficacy (the effect of the drug on the body) of AKP-11 administered to participants with atopic dermatitis. You are invited to … Continue reading Atopic Dermatitis
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Genital Psoriasis If you have psoriasis with genital involvement, you’re not alone. Up to two thirds of people with psoriasis report genital involvement at some point during their lives. That’s … Continue reading Genital Psoriasis
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
AKP-11 is being developed as a treatment for psoriasis. AKP-11 has been tested on a small population of psoriasis subjects previously, which showed a reduction in psoriasis severity. By participating … Continue reading Mild To Moderate Plaque Psoriasis
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
Are you aged 40 years or over? Do you suffer from COPD? Are you a current or previous smoker? Using Seretide? If you answered yes to these questions, you may be … Continue reading COPD – FLASH STUDY – Multi-centre
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 40 and above
TRIAL STATUS: Completed
people suffering with Acute Pain 1 visit of approximately 2 hours assessing a survey for people affected by Acute Pain in Australia If you suffer from Acute Pain or know someone who does, contact us for … Continue reading ACUTE PAIN – Survey Assessment
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
people suffering with Chronic Pain 1 visit of approximately 2 hours assessing a survey for people affected by Chronic Pain in Australia If you suffer from Chronic Pain or know someone who does, … Continue reading CHRONIC PAIN – Survey Assessment
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
If you answered yes to these questions, you may be able to take part in a new research study. Our Research Centre in Drummoyne is participating in the study. … Continue reading COPD – FLASH Study
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
This is a Phase 3, multi centre, open label, long term (up to 52 weeks) study of the safety and efficacy of esketamine administered by nasal spray in treatment resistant depression. Study participants will … Continue reading An Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting